Cardiovascular Systems, Inc.

Summary

Profile

Financials

Events

Ownership

Options

Company Info

Industry	Medical Specialties
Sector	Health Technology
Employees	780
CEO	Mr. Scott R. Ward

Address	1225 Old Highway 8 NW , St. Paul, MN 55112
Phone	1.651.259.1600
Website	www.csi360.com

Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.

Competitors

Company Name	3 Month %Change	1 Year %Change
Cardiovascular Systems, Inc.	-45.99%	-46.18%
Treace Medical Concepts, Inc.	-31.18%	n/a
Arcturus Therapeutics Holdings, Inc.	-31.82%	-65.16%
Amphastar Pharmaceuticals, Inc.	0.61%	16.33%
Heron Therapeutics, Inc.	-26.00%	-47.63%

Statement Summary

as of 4:00 ET PM 12/03/2021

Total Assets (MRQ)	332.3 M
Total Liabilities (MRQ)	69.1 M
Shareholders’ Equity (MRQ)	263.2 M
Total Revenue (Annual)	58.4 M
Net Income (Annual)	-8.6 M

Earnings And Estimates

as of 4:00 ET PM 12/03/2021

Current Qtr EPS Estimate	-0.14
Current FY EPS Estimate	-0.46
Long Term EPS Growth Estimate	-139.28
Next Expected Earnings Date	//

CSII vs S&P 500

as of 12/03/2021

	Relative To S&P 500	CSII
4 Weeks	n/a	n/a
12 Weeks	n/a	n/a
YTD	n/a	n/a

Earnings Surprises

as of 4:00 ET PM 12/03/2021

Fiscal Quarter	Estimate	Actual	Surprise
09/2021	-0.10	-0.22	+117.82%
06/2021	-0.17	-0.14	-15.44%
03/2021	-0.11	-0.15	+42.10%
12/2020	-0.06	0.00	-100.00%
09/2020	-0.22	-0.05	-77.17%
06/2020	-0.46	-0.43	-5.59%
03/2020	-0.09	-0.08	-5.88%
12/2019	-0.02	-0.10	+370.59%

Financial Strength

as of 4:00 ET PM 12/03/2021

Pre-Tax Margin	-14.53
Net Margin	-330.59
Operating Margin	-13.90
Return On Equity	-7.51
Return On Assets	-5.92
Inventory Turnover (TTM)	2.06
Sales Growth (MRQ)	7.92

Ratios

as of 4:00 PM ET 12/03/2021

Price/Earnings (TTM)	n/a
Price/Book (MRQ)	2.93
Price/Cash Flow (TTM)	0.00
Book Value (MRQ)	6.49
Quick Ratio (MRQ)	5.34
Current Ratio (MRQ)	6.11
Total Debt/Equity (MRQ)	0.09

Short Interest

as of 4:00 PM ET 12/06/2021

	% Short - 0.00%
	% Remaining Float - 100.00%

	Current	Last Month
Short Interest Date	n/a	n/a
Short Interest Shares	0	0
Short Interest Ratio	0.0	0.0

M Y M Y

Total Assets 0,0.00 0,0.00

Total Liabilities 0,0.00 0,0.00

Total Equity 0,0.00 0,0.00

M Y M Y

Total Revenue 0,0.00 0,0.00

EBT Exc.
Unusual Items 0,0.00 0,0.00

Net Income 0,0.00 0,0.00

M Y M Y

Cash from
Operations 0,0.00 0,0.00

Cash from
Activities 0,0.00 0,0.00

Cash from
Fin. Activities 0,0.00 0,0.00

Select Period

TOTAL ASSETS	TOTAL LIABILITIES	TOTAL EQUITY

Balance Sheet

	M Y
ASSETS
Cash And Equivalents	0,0.00
Receivables	0,0.00
Inventories	0,0.00
Other Current Assets	0,0.00
Total Current Assets	0,0.00
Property, Plant & Equipment, Gross	0,0.00
Accumulated Depreciation & Depletion	0,0.00
Property, Plant & Equipment, Net	0,0.00
Intangibles	0,0.00
Other Non-Current Assets	0,0.00
Total Non-Current Assets	0,0.00
TOTAL ASSETS	0,0.00
Liabilities & Shareholder Equity
Accounts Payable	0,0.00
Short Term Debt	0,0.00
Total Current Liabilities	0,0.00
Long Term Debt	0,0.00
Deferred Income Taxes	0,0.00
Other Non-Current Liabilities	0,0.00
Minority Interest	0,0.00
Total Non-Current Liabilities	0,0.00
Preferred Stock Equity	0,0.00
Common Stock Equity	0,0.00
Common Par	0,0.00
Additional Paid In Capital	0,0.00
Cumulative Translation Adjustment	0,0.00
Retained Earnings	0,0.00
Treasury Stock	0,0.00
Other Equity Adjustments	0,0.00
Total Capitalization	0,0.00
TOTAL EQUITY	0,0.00
TOTAL LIABILITIES & STOCK EQUITY	0,0.00
Total Common Shares Outstanding	0,0.00
Preferred Shares	0,0.00
Treasury Shares	0,0.00
Basic Weighted Shares Outstanding	0,0.00
Diluted Weighted Shares Outstanding	0,0.00
Number Of Employees	0,0.00
Number Of Part-Time Employees	0,0.00

Select Period

TOTAL REVENUES	EBT Excluding Unusual Items	NET INCOME

Income Statement

	M Y
Sales	0,0.00
Cost Of Sales	0,0.00
Gross Operating Profit	0,0.00
Selling, General, And Administrative Expenses	0,0.00
Research & Development	0,0.00
Operating Income Before D & A (EBITDA)	0,0.00
Depreciation & Amortization	0,0.00
Interest Income	0,0.00
Other Income - Net	0,0.00
Special Income / Charges	0,0.00
Total Income Before Interest Expenses (EBIT)	0,0.00
Interest Expense	0,0.00
Pre-Tax Income	0,0.00
Income Taxes	0,0.00
Minority Interest	0,0.00
Net Income From Continuing Operations	0,0.00
Net Income From Discontinued Operations	0,0.00
Net Income From Total Operations	0,0.00
Extraordinary Income/Losses	0,0.00
Income From Cum. Effect Of Acct. Change	0,0.00
Income From Tax Loss Carryforward	0,0.00
Other Gains / Losses	0,0.00
Total Net Income	0,0.00
Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge)	0,0.00
Preferred Dividends	0,0.00
Net Income Available To Common	0,0.00
Basic EPS From Continuing Ops.	0,0.00
Basic EPS From Discontinued Ops.	0,0.00
Basic EPS From Total Operations	0,0.00
Basic EPS From Extraordinary Inc.	0,0.00
Basic EPS From Cum Effect Of Accounting Change	0,0.00
Basic EPS From Tax Loss Carryf'd.	0,0.00
Basic EPS From Other Gains (Losses)	0,0.00
Basic EPS, Total	0,0.00
Basic Normalized Net Income/Share	0,0.00
EPS From Continuing Ops.	0,0.00
EPS From Discontinued Ops	0,0.00
EPS From Total Ops.	0,0.00
EPS From Extraord. Inc.	0,0.00
EPS From Cum Effect of Accounting Change	0,0.00
EPS From Tax Loss Carfd.	0,0.00
EPS From Other Gains (L)	0,0.00
EPS, Total	0,0.00
Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge)	0,0.00
Dividends Paid Per Share	0,0.00

Select Period

CASH FROM OPERATIONS	CASH FROM INVESTING ACTIVITIES	CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

	M Y
Cash Flow From Operating Activities
Net Income (Loss)	0,0.00
Operating Gains/Losses	0,0.00
Gross Operating Profit	0,0.00
(Increase) Decrease In Receivables	0,0.00
(Increase) Decrease In Inventories	0,0.00
(Increase) Decrease In Other Current Assets	0,0.00
(Decrease) Increase In Other Current Liabilities	0,0.00
(Increase) Decrease In Other Working Capital	0,0.00
Other Non-Cash Items	0,0.00
Net Cash From Continuing Operations	0,0.00
Net Cash From Discontinued Operations	0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities	0,0.00
Sale Of Property, Plant & Equipment	0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments	0,0.00
Purchases Of Property, Plant & Equipment	0,0.00
Acquisitions	0,0.00
Purchases Of Short-Term Investments	0,0.00
Other Cash From Investing Activities	0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities	0,0.00
Issuance Of Debt	0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock	0,0.00
Repayment Of Long-Term Debt	0,0.00
Repurchase Of Capital Stock	0,0.00
Payment Of Cash Dividends	0,0.00
Other Financing Charges, Net	0,0.00
Net Cash From Financing Activities	0,0.00
Effect Of Exchange Rate Changes	0,0.00
Net Change In Cash & Cash Equivalents	0,0.00

Earnings Estimates

as of 4:00 ET PM 12/03/2021

	Current Qtr (12/2021)	Next Qtr (03/2022)
Consensus Estimate	$-0.14	$-0.07
# of Estimates	8	8
High Estimate	$-0.07	$-0.04
Low Estimate	$-0.19	$-0.12
Year Ago EPS	$0.00	$-0.15
Year Over Year Growth Estimate	9,632.14%	-52.20%

	Current Yr (06/2022)	Next Yr (06/2023)
Consensus Estimate	$-0.46	$-0.17
# of Estimates	8	7
High Estimate	$-0.40	$0.05
Low Estimate	$-0.52	$-0.36
Year Ago EPS	$-0.35	$-0.46
Year Over Year Growth Estimate	31.43%	-63.66%

	Current Qtr (12/2021)	Next Qtr (03/2022)	Current Year (06/2022)	Next Year (06/2023)
Consensus Estimate	$-0.14	$-0.07	$-0.46	$-0.17
# of Estimates	8	8	8	7
High Estimate	$-0.07	$-0.04	$-0.40	$0.05
Low Estimate	$-0.19	$-0.12	$-0.52	$-0.36
Year Ago EPS	$0.00	$-0.15	$-0.35	$-0.46
Year Over Year Growth Estimate	9,632.14%	-52.20%	31.43%	-63.66%

Insider Information Summary

as of 11/30/2021

	% Insiders - 3.40%
	% Remaining Total Shares - 96.60%

	Current	1 Month
Net Insider Transaction	364.00	156.57 K
Shares Bought	1.22 K	294.80 K
Shares Sold	858.00	138.24 K

Insider Activity

Purchases

Sales

Options Exercised

Options Awarded

Transaction Date	Insider/Title	Transaction Type	Market Value	Shares	Average Price	Current Holdings

Learn to Trade Like a Pro

Master The Market with the Help of Our Financial Experts

SUBSCRIBE NOW

STOCKS

CSII

By Amanda Schiavo

Apr 18, 2017 8:36 AM EDT

Latest News

New Lifetime High Reached By WGL Holdings (WGL)

Apr 1, 2016 10:06 AM EDT

5 Things You Must Know Before the Market Opens Friday

Mar 4, 2016 7:28 AM EST

Incyte, Skyworks Solutions, Western Digital, Constellation Brands: 'Mad Money' Lightning Round

Mar 2, 2016 10:46 AM EST

3 Leisure Stocks Pushing Industry Growth

Jan 26, 2016 10:00 AM EST

Trade-Ideas: MetLife (MET) Is Today's Post-Market Leader Stock

Jan 22, 2016 10:22 AM EST

Trade-Ideas: Marvell Technology Group (MRVL) Is Today's Post-Market Leader Stock

Nov 5, 2015 10:02 AM EST

Oct 9, 2015 12:35 PM EDT

Corbus Pharmaceuticals (CRBP) Stock Closed Sharply Higher, Cantor Fitzgerald Initiates Coverage

Oct 8, 2015 1:07 PM EDT

Jul 9, 2015 8:58 AM EDT

Drug Giant Eli Lilly Wants to Save Money So it Brought in These New Bigwigs

May 27, 2015 9:10 AM EDT

Insider Trading Alert - AEL, ANIP And CRM Traded By Insiders

May 6, 2015 10:30 AM EDT

Dow Jones (DJIA) Today: Goldman Sachs Group (GS) Higher

Apr 30, 2015 10:05 AM EDT

Mar 3, 2015 11:15 AM EST

3 Basic Materials Stocks Driving The Sector Higher

Mar 2, 2015 12:30 PM EST

Feb 26, 2015 1:15 PM EST

Insider Trading Alert - RYL, BHB And AAL Traded By Insiders

Feb 17, 2015 12:45 PM EST

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: SBW, HIO, ETG

Feb 4, 2015 12:13 PM EST

Jones Lang LaSalle (JLL) Reaches New Lifetime High Today

Jan 29, 2015 10:07 AM EST

May 13, 2014 10:50 AM EDT

May 6, 2014 2:00 PM EDT

Apr 29, 2014 10:30 AM EDT

4 Under-$10 Biotech Stocks in Breakout Territory

Mar 21, 2013 7:48 AM EDT

Oct 21, 2011 9:21 AM EDT

Oct 13, 2011 10:50 AM EDT

Recent Articles from TheStreet

Darkened photo of numbers on an LED display with text overlay that reads "What Are Outstanding Shares?"

JIM CRAMER

Jim Cramer says investors should ignore pre-market jitters and focus on the three things the market really cares about.

POLITICS

TWTR

Devin Nunes will be resigning from Congress to take a role at former President Donald Trump's new media company.

INVESTING

Earnings reports are still coming in for some Wall Street favorites.

INVESTING

TWTR

While some hypothesize that Twitter has reached its limit for growth as a company, others believe the current downturn offers a valuable buying opportunity.

What We're Looking for From Papa John's Earnings

INVESTING

Pizza maker is making more dough than expected.

INVESTING

JPMorgan and other market strategists have also singled out a hawkish turn by central banks as the main risk to their outlook for stocks over Covid-19.